2017
DOI: 10.1016/j.celrep.2017.04.069
|View full text |Cite
|
Sign up to set email alerts
|

Wolf-Hirschhorn Syndrome Candidate 1 Is Necessary for Correct Hematopoietic and B Cell Development

Abstract: SUMMARY Immunodeficiency is one of the most important causes of mortality associated to Wolf-Hirschhorn Syndrome (WHS), a severe rare disease originated by a deletion in chromosome 4p. The WHS candidate 1 (WHSC1) gene has been proposed as one of the main responsible for many of the alterations in WHS, but its mechanism of action is still unknown. Here, we present in vivo genetic evidence showing that Whsc1 plays an important role at several points of hematopoietic development. Particularly, our results demonst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
28
0
5

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(34 citation statements)
references
References 38 publications
1
28
0
5
Order By: Relevance
“…So far the reported SALL4-interacting epigenetic factors (see Figure 5) include: DNA methyltransferases DNMT-1, -3A, -3B, -3 L, methyl-CpG-binding domain 2 protein (MBD2) [84]; NuRD complex that contains histone deacetylases HDAC1/2 [79]; H3K4 methyltransferase MLL1 [77]; H3K79 methyltransferase DOT1L [46]; H3K36 methyltransferase Wolf-Hirschhorn syndrome candidate 1 (WHSC1) [85,86]; and lysine-specific histone demethylase LSD1/KDM1A [46,81,87]. All of these are critical regulators in normal blood development and are frequent targets for dysregulation in hematological malignancies [88][89][90], and clinical epigenetic remedies inhibiting such epigenetic factors have been shown effective in treating leukemia [91][92][93].…”
Section: Sall4 Interacts With a Variety Of Epigenetic Factors To Regumentioning
confidence: 99%
“…So far the reported SALL4-interacting epigenetic factors (see Figure 5) include: DNA methyltransferases DNMT-1, -3A, -3B, -3 L, methyl-CpG-binding domain 2 protein (MBD2) [84]; NuRD complex that contains histone deacetylases HDAC1/2 [79]; H3K4 methyltransferase MLL1 [77]; H3K79 methyltransferase DOT1L [46]; H3K36 methyltransferase Wolf-Hirschhorn syndrome candidate 1 (WHSC1) [85,86]; and lysine-specific histone demethylase LSD1/KDM1A [46,81,87]. All of these are critical regulators in normal blood development and are frequent targets for dysregulation in hematological malignancies [88][89][90], and clinical epigenetic remedies inhibiting such epigenetic factors have been shown effective in treating leukemia [91][92][93].…”
Section: Sall4 Interacts With a Variety Of Epigenetic Factors To Regumentioning
confidence: 99%
“…РОССИЙСКИЙ ВЕСТНИК ПЕРИНАТОЛОГИИ И ПЕДИАТРИИ, 2019; 64: (5) ROSSIYSKIY VESTNIK PERINATOLOGII I PEDIATRII, 2019; 64: (5) рожденных. Основные проявления синдрома: умственная отсталость от легкой до тяжелой степени, мышечная гипотония, задержка физического развития, судороги и характерный лицевой фенотип.…”
unclassified
“…В результате картирования были выявлены две перекрывающиеся делеции в регионе WHSCR разного размера, определяющие критическую область синдрома Вольфа-Хиршхорна 1 и 2 (WHSCR1-2) [2,3,5]. Предполагается, что эти регионы ответственны как минимум за два основных клинических проявления синдрома -задержку психофизического развития и лицевой дизморфизм [4].…”
unclassified
See 2 more Smart Citations